Tag: dosage forms

Multi-Dose Ophthalmic Products: Preservative Efficacy and Microbial Limits Multi-Dose Ophthalmic Products: Ensuring Preservative Efficacy and Controlling Microbial Limits In the pharmaceutical production of multidose ophthalmic products, addressing preservative efficacy and establishing appropriate microbial limits are of paramount importance to meet stringent GMP requirements across the US, UK, and EU markets. These products present unique microbiological…

Read More “Multi-Dose Ophthalmic Products: Preservative Efficacy and Microbial Limits” »

Blow–Fill–Seal (BFS) Technology: GMP Controls for Ophthalmic and Inhalation Products GMP Controls for Blow–Fill–Seal (BFS) Technology in Ophthalmic and Inhalation Products: A Step-by-Step Guide Pharmaceutical manufacturers operating within the US, UK, and European Union must sustain rigorous quality standards across diverse dosage forms such as solid oral, parenteral, and topical products. Among sterilization and aseptic…

Read More “Blow–Fill–Seal (BFS) Technology: GMP Controls for Ophthalmic and Inhalation Products” »

Nasal Sprays and Drops: GMP Controls for Delivered Dose and Spray Pattern GMP Controls for Delivered Dose and Spray Pattern in Nasal Sprays and Drops: A Step-by-Step Guide The pharmaceutical industry continually evolves with diversified dosage forms, including solid oral preparations, parenteral injections, and topical products. Among topical dosage forms, nasal sprays and drops occupy…

Read More “Nasal Sprays and Drops: GMP Controls for Delivered Dose and Spray Pattern” »

GMP for Lyophilized Products: Cake Appearance, Residual Moisture and Reconstitution Comprehensive GMP Guide for Lyophilized Products: Cake Appearance, Residual Moisture, and Reconstitution Lyophilized products, often referred to as freeze-dried pharmaceuticals, represent a critical dosage form within the sterile parenteral manufacturing sphere. Their unique requirements under Good Manufacturing Practice (GMP) guidelines demand precise control over formulation,…

Read More “GMP for Lyophilized Products: Cake Appearance, Residual Moisture and Reconstitution” »

Handling and Filling of Highly Viscous or Sensitive Injectable Solutions: GMP Best Practices Step-by-Step Guide for Handling and Filling Highly Viscous or Sensitive Injectable Solutions Under GMP Within the pharmaceutical manufacturing landscape, the production of parenteral dosage forms—specifically highly viscous or sensitive injectable solutions—poses unique challenges. These products require strict adherence to Good Manufacturing Practice…

Read More “Handling and Filling of Highly Viscous or Sensitive Injectable Solutions” »

Biologics Drug Product GMP: Protein Stability, Aggregation and Contamination Control Biologics Drug Product GMP: Ensuring Protein Stability, Aggregation and Contamination Control Across Dosage Forms Biologics drug products present critical manufacturing challenges distinct from small-molecule pharmaceuticals, stemming primarily from the complex nature of proteins and related macromolecules. Control of protein stability, prevention of aggregation, and robust…

Read More “Biologics Drug Product GMP: Protein Stability, Aggregation and Contamination Control” »

Monoclonal Antibody Drug Products: GMP Controls for Formulation and Filling Ensuring GMP Compliance in Formulation and Filling of Monoclonal Antibody Drug Products Monoclonal antibody (mAb) drug products are a vital class of biopharmaceuticals with significant therapeutic applications. Due to their complex nature and route of administration, robust Good Manufacturing Practice (GMP) controls are critical during…

Read More “Monoclonal Antibody Drug Products: GMP Controls for Formulation and Filling” »

Biosimilar Drug Product GMP: Comparability, Consistency and Lifecycle Controls Biosimilar Drug Product GMP: Ensuring Comparability, Consistency, and Lifecycle Controls Manufacturing biosimilar drug products in compliance with Good Manufacturing Practice (GMP) demands rigorous adherence to regulatory requirements spanning multiple dosage forms. This tutorial presents a comprehensive, step-by-step approach for pharmaceutical professionals tasked with ensuring the GMP-compliant…

Read More “Biosimilar Drug Product GMP: Comparability, Consistency and Lifecycle Controls” »

Small-Volume Parenterals: GMP Controls for Fill Volume and Particulate Matter Ensuring GMP Compliance in Small-Volume Parenterals: Effective Controls for Fill Volume and Particulate Matter Small-volume parenterals (SVPs) represent a critical category of dosage forms that demand rigorous GMP controls to guarantee patient safety and product quality. Unlike solid oral dosage forms such as tablets or…

Read More “Small-Volume Parenterals: GMP Controls for Fill Volume and Particulate Matter” »

Large-Volume Parenterals: Sterility, Pyrogen Control and Container Integrity Ensuring GMP Compliance in Large-Volume Parenterals: A Step-by-Step Tutorial on Sterility, Pyrogen Control, and Container Integrity Large-volume parenterals (LVPs) play a critical role in pharmaceutical therapy, serving as primary vehicles for intravenous administration. Given their mode of delivery directly into the bloodstream or body cavities, ensuring strict…

Read More “Large-Volume Parenterals: Sterility, Pyrogen Control and Container Integrity” »